Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 58.50
+1.30 (2.27%)
Feb 10, 2026, 11:32 AM CET
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 770.57 million as of February 10, 2026. Its market cap has increased by 37.50% in one year.
Market Cap
770.57M
Enterprise Value
626.56M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
58.50
Market Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 770.57M, an increase of 310.99%. That is a compound annual growth rate of 15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 770.57M | 13.27% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.35B |
| Cantargia AB | 1.32B |
| SynAct Pharma AB | 1.16B |
| Xspray Pharma AB | 968.42M |
| Oncopeptides AB | 755.40M |
| FluoGuide | 565.69M |
| Corline Biomedical AB | 409.82M |
| Ascelia Pharma AB | 353.96M |